2
RESEARCH METHODOLOGY
38
5
MARKET OVERVIEW
AI-driven hybrid imaging and personalized medicine fuel rapid theranostics market growth amidst infrastructure expansion.
58
5.2.1.1
Rapid expansion of theranostics
5.2.1.2
Technological advancements in hybrid imaging modalities
5.2.1.3
Favorable government support and expanding healthcare infrastructure
5.2.1.4
Advancements in radiotracers and radiopharmaceuticals
5.2.1.5
Integration of AI into nuclear medicine equipment
5.2.2.1
Capital-intensive nature of equipment
5.2.2.2
Short half-life of radiopharmaceuticals
5.2.2.3
High maintenance and operational costs
5.2.2.4
Shortage of trained personnel
5.2.3.1
Growing preference for personalized and precision medicine
5.2.3.2
Telemedicine and cloud-native platforms & mobile/remote imaging capabilities
5.2.4.1
Global isotope supply chain instability
5.2.4.2
Cybersecurity and data privacy issues in imaging IT
5.3
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4.1
SHIFT TOWARD HYBRID AND MULTI-MODALITY IMAGING SYSTEMS
5.4.2
ADVANCEMENTS IN DETECTOR TECHNOLOGIES AND IMAGE QUALITY
5.4.3
GROWING DEMAND FOR COMPACT AND VERSATILE SYSTEMS
5.4.4
INTEGRATION OF ARTIFICIAL INTELLIGENCE AND AUTOMATION
5.4.5
CONNECTIVITY AND CLOUD-ENABLED WORKFLOWS
5.5.2
INDICATIVE PRICE OF NUCLEAR MEDICINE EQUIPMENT, BY KEY PLAYER
5.5.3
INDICATIVE PRICE OF NUCLEAR MEDICINE EQUIPMENT, BY REGION
5.5.4
AVERAGE SELLING PRICE OF NUCLEAR CARDIOLOGY REPORTING SOFTWARE
5.8
INVESTMENT AND FUNDING SCENARIO
5.9.1.1
Hybrid imaging systems
5.9.1.2
Digital detection technology
5.9.1.3
Artificial Intelligence (AI) and advanced image reconstruction techniques
5.9.1.4
Time-of-Flight (TOF) technology
5.9.1.5
Solid-state detector technology
5.9.2
COMPLEMENTARY TECHNOLOGIES
5.9.2.1
Radiopharmaceutical development and theranostics
5.9.2.2
Advanced computing and big data analytics
5.9.2.3
Robotics and automated dose dispensing systems
5.9.3
ADJACENT TECHNOLOGIES
5.9.3.1
Magnetic Resonance Imaging (MRI) integration
5.9.3.2
Computed Tomography (CT) advancements
5.11.1
IMPORT DATA FOR HS CODE 901814
5.11.2
EXPORT DATA FOR HS CODE 901814
5.12
KEY CONFERENCES AND EVENTS, 2025–2026
5.13.1
PRECISION IN NUCLEAR MEDICINE WITH NATIONAL STANDARD TRACEABILITY
5.13.2
MULTI-MODALITY IMAGE FUSION FOR IMPROVED DIAGNOSTICS
5.13.3
REMOTE CONSULTATION WITH CLOUD-BASED NUCLEAR MEDICINE ANALYSIS
5.14
TARIFF AND REGULATORY LANDSCAPE
5.14.1
TARIFF DATA FOR HS CODE 901814
5.14.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.14.3
REGULATORY ANALYSIS
5.15
PORTER’S FIVE FORCES ANALYSIS
5.15.1
BARGAINING POWER OF SUPPLIERS
5.15.2
BARGAINING POWER OF BUYERS
5.15.3
THREAT OF NEW ENTRANTS
5.15.4
THREAT OF SUBSTITUTES
5.15.5
INTENSITY OF COMPETITIVE RIVALRY
5.16
KEY STAKEHOLDERS AND BUYING CRITERIA
5.16.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.17.2
END-USER EXPECTATIONS
5.18.1
DIRECT EQUIPMENT SALES MODEL
5.18.2
SERVICE AND MAINTENANCE CONTRACTS
5.18.3
PAY-PER-SCAN (OR PAY-PER-USE) MODEL
5.18.4
EQUIPMENT LEASING AND FINANCING SOLUTIONS
5.18.5
INTEGRATED SOLUTIONS AND MANAGED SERVICES
5.18.6
SOFTWARE AND DATA ANALYTICS SUBSCRIPTION
5.19.2
MARKET POTENTIAL OF AI/GEN AI
5.19.3
CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
5.19.3.1
AI-based low-dose PET image reconstruction
5.19.3.2
Dose-aware diffusion models for 3D low-dose PET
5.19.4
IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
5.19.4.1
Medical image analysis software
5.19.4.2
Radiology information systems
5.19.4.3
Clinical decision support systems
5.19.5
USER READINESS AND IMPACT ASSESSMENT
5.19.5.2
Impact assessment
5.20
IMPACT OF 2025 US TARIFF - OVERVIEW
5.20.3
PRICE IMPACT ANALYSIS
5.20.3.1
Capital equipment (cyclotrons, PET/SPECT systems)
5.20.3.3
Key materials: semiconductors, detectors, shielding
5.20.3.4
Service parts, maintenance, and global supply chains
5.20.4
IMPACT ON COUNTRY/REGION
5.20.5
IMPACT ON END-USE INDUSTRIES
5.20.5.2
Diagnostic imaging centers
5.20.5.3
Cancer treatment centers
6
NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 27 Data Tables
112
6.2.3
GAMMA/SCINTILLATION CAMERAS
6.2.3.1
Clinical versatility and lower cost to expedite growth
6.3
NON-IMAGING MODALITIES
6.3.1.1
Ease of use, portability, and critical role in maintaining workplace safety to spur growth
6.3.2.1
Increasing development in digital interfaces, automatic isotope recognition, and real-time data logging to bolster growth
6.3.3
PROBE COUNTING SYSTEMS
6.3.3.1
Technological advancements in probe counting systems to contribute to growth
6.3.4
GAMMA WELL COUNTERS
6.3.4.1
Growing use of gamma well counters in laboratory-based applications to propel market
6.3.5
OTHER NON-IMAGING MODALITIES
7
NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 12 Data Tables
131
7.2.1
IMPROVEMENTS IN IMAGING ACCURACY AND TREATMENT PLANNING TO STIMULATE GROWTH
7.3.1
ESCALATING GLOBAL BURDEN OF NEURODEGENERATIVE DISORDERS AND OTHER NEUROLOGICAL CONDITIONS TO AID GROWTH
7.4.1
PERSISTENT GLOBAL BURDEN OF CARDIOVASCULAR DISEASES TO FACILITATE GROWTH
7.5.1
GROWING PREVALENCE OF DEGENERATIVE JOINT DISEASES, SPORTS INJURIES, AND OSTEOPOROSIS TO BOOST MARKET
7.6.1
GLOBAL PREVALENCE OF HYPER- AND HYPOTHYROIDISM AND THYROID CANCER TO AUGMENT GROWTH
7.7
OTHER THERAPEUTIC AREAS
8
NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 5 Data Tables
141
8.2.1
WIDE AVAILABILITY, EASE OF INTEGRATION, AND ESTABLISHED PRESENCE IN CLINICAL WORKFLOW TO AID GROWTH
8.3.1
GROWING RELIANCE ON ADVANCED IMAGING TECHNOLOGIES TO FUEL MARKET
9
NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 9 Data Tables
145
9.2.1
CONTINUOUS TECHNOLOGICAL ADVANCEMENTS TO FOSTER GROWTH
9.3
DIAGNOSTIC IMAGING CENTERS
9.3.1
GROWING DEMAND FOR EARLY AND PRECISE DIAGNOSIS TO DRIVE MARKET
9.4
CANCER TREATMENT CENTERS
9.4.1
ESCALATING GLOBAL INCIDENCE OF CANCER TO PROMOTE GROWTH
10
NUCLEAR MEDICINE EQUIPMENT MARKET, BY REGION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 211 Data Tables
152
10.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2.1
Advancements in PET and SPECT equipment for personalized care to aid growth
10.2.3.1
Increasing adoption of advanced imaging technologies to support growth
10.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2.1
Increasing adoption of hybrid imaging systems to spur growth
10.3.3.1
Favorable clinical guidelines supporting wider use of PET-CT to fuel market
10.3.4.1
Shift to hybrid imaging to accelerate growth
10.3.5.1
Robust network of scanners to facilitate growth
10.3.6.1
Growing integration of cutting-edge technologies into clinical practice to propel market
10.3.7.1
Rapid shift toward PET procedures to accelerate growth
10.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2.1
Ongoing innovations in equipment and growing reliance on nuclear imaging for accurate detection to drive market
10.4.3.1
Rapid investments in medical infrastructure and technological advancements in image analysis to spur growth
10.4.4.1
Substantial cancer and cardiovascular disease burden to encourage growth
10.4.5.1
Universal health coverage to bolster growth
10.4.6.1
Strong diagnostic imaging network and widespread adoption of hybrid imaging technologies to contribute to growth
10.4.7
REST OF ASIA PACIFIC
10.5
MIDDLE EAST & AFRICA
10.5.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.5.2.1
Growing healthcare needs and favorable government support to boost market
10.5.3
REST OF MIDDLE EAST & AFRICA
10.6.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.6.2.1
Healthcare modernization efforts to accelerate growth
10.6.3.1
Expanding healthcare infrastructure to bolster growth
10.6.4
REST OF LATIN AMERICA
11
COMPETITIVE LANDSCAPE
Discover strategic dominance and emerging leaders in the nuclear medicine equipment market.
240
11.2
KEY PLAYER STRATEGIES
11.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NUCLEAR MEDICINE EQUIPMENT MARKET
11.3
REVENUE ANALYSIS, 2020–2024
11.4
MARKET SHARE ANALYSIS, 2024
11.4.1
POSITRON EMISSION TOMOGRAPHY (PET) EQUIPMENT
11.4.2
SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) EQUIPMENT
11.5
MARKET RANKING ANALYSIS
11.6
BRAND/PRODUCT COMPARISON
11.7
COMPANY VALUATION AND FINANCIAL METRICS
11.8
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.8.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.8.5.1
Company footprint
11.8.5.2
Region footprint
11.8.5.3
System type footprint
11.8.5.4
Therapeutic area footprint
11.8.5.5
Dimension footprint
11.8.5.6
End-user footprint
11.9
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
11.9.1
PROGRESSIVE COMPANIES
11.9.2
RESPONSIVE COMPANIES
11.9.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
11.9.5.1
Detailed list of key startups/SMEs
11.9.5.2
Competitive benchmarking of startups/SMEs
11.10
COMPETITIVE SCENARIO
11.10.1
PRODUCT LAUNCHES AND APPROVALS
11.10.4
OTHER DEVELOPMENTS
12
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
269
12.1.1.1
Business overview
12.1.1.2
Products offered
12.1.1.3
Recent developments
12.1.2
SIEMENS HEALTHINEERS AG
12.1.3
KONINKLIJKE PHILIPS N.V.
12.1.4
MIRION TECHNOLOGIES, INC.
12.1.5
CANON MEDICAL SYSTEMS CORPORATION
12.1.6
HERMES MEDICAL SOLUTIONS
12.1.8
SEGAMI CORPORATION
12.1.9
WINKGEN MEDICAL SYSTEMS GMBH & CO. KG
12.1.13
LABLOGIC SYSTEMS LTD.
12.1.17
SPECTRUM DYNAMICS MEDICAL
12.1.18
NEUSOFT MEDICAL SYSTEMS CO., LTD.
12.2.3
ITM ISOTOPE TECHNOLOGIES MUNICH SE
13.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3
CUSTOMIZATION OPTIONS
TABLE 1
NUCLEAR MEDICINE EQUIPMENT MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2
EXCHANGE RATES UTILIZED FOR CONVERSION TO USD, 2021–2024
TABLE 3
NUCLEAR MEDICINE EQUIPMENT MARKET: RESEARCH ASSUMPTIONS
TABLE 4
NUCLEAR MEDICINE EQUIPMENT MARKET: RISK ASSESSMENT
TABLE 5
NUCLEAR MEDICINE EQUIPMENT MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
TABLE 6
INDICATIVE PRICE OF NUCLEAR MEDICINE EQUIPMENT, BY KEY PLAYER, 2024 (USD)
TABLE 7
INDICATIVE PRICE OF NUCLEAR MEDICINE EQUIPMENT, BY REGION, 2024 (USD)
TABLE 8
AVERAGE SELLING PRICE OF NUCLEAR CARDIOLOGY REPORTING SOFTWARE, 2024 (USD)
TABLE 9
NUCLEAR MEDICINE EQUIPMENT MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 10
JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR NUCLEAR MEDICINE EQUIPMENT MARKET, 2025
TABLE 11
IMPORT DATA FOR HS CODE 901814, BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 12
EXPORTS DATA FOR HS CODE 901814, BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 13
NUCLEAR MEDICINE EQUIPMENT MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
TABLE 14
TARIFF DATA FOR HS CODE 901814
TABLE 15
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18
REGULATORY STANDARDS IN NUCLEAR MEDICINE
TABLE 19
REGULATORY REQUIREMENTS IN NORTH AMERICA
TABLE 20
REGULATORY REQUIREMENTS IN EUROPE
TABLE 21
REGULATORY REQUIREMENTS IN ASIA PACIFIC
TABLE 22
REGULATORY REQUIREMENTS IN LATIN AMERICA
TABLE 23
REGULATORY REQUIREMENTS IN MIDDLE EAST & AFRICA
TABLE 24
NUCLEAR MEDICINE EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 25
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)
TABLE 26
KEY BUYING CRITERIA FOR END USERS
TABLE 27
UNMET NEEDS IN NUCLEAR MEDICINE EQUIPMENT MARKET
TABLE 28
END-USER EXPECTATIONS IN NUCLEAR MEDICINE EQUIPMENT MARKET
TABLE 29
US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 30
NUCLEAR MEDICINE EQUIPMENT, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 31
NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 32
NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 33
NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (UNITS)
TABLE 34
PET EQUIPMENT OFFERED BY MAJOR PLAYERS
TABLE 35
NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 36
NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY REGION,2023–2030 (USD MILLION)
TABLE 37
NUCLEAR MEDICINE EQUIPMENT MARKET FOR STANDALONE PET, BY REGION, 2023–2030 (USD MILLION)
TABLE 38
NUCLEAR MEDICINE EQUIPMENT MARKET FOR HYBRID PET, BY REGION, 2023–2030 (USD MILLION)
TABLE 39
SPECT EQUIPMENT OFFERED BY MAJOR PLAYERS
TABLE 40
NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 41
NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY REGION, 2023–2030 (USD MILLION)
TABLE 42
NUCLEAR MEDICINE EQUIPMENT MARKET FOR STANDALONE SPECT, BY REGION, 2023–2030 (USD MILLION)
TABLE 43
NUCLEAR MEDICINE EQUIPMENT MARKET FOR HYBRID SPECT, BY REGION, 2023–2030 (USD MILLION)
TABLE 44
GAMMA/SCINTILLATION CAMERAS OFFERED BY MAJOR PLAYERS
TABLE 45
NUCLEAR MEDICINE EQUIPMENT MARKET FOR GAMMA/SCINTILLATION CAMERAS, BY REGION, 2023–2030 (USD MILLION)
TABLE 46
NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 47
NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 48
GM COUNTERS OFFERED BY MAJOR PLAYERS
TABLE 49
NUCLEAR MEDICINE EQUIPMENT MARKET FOR GM COUNTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 50
DOSE CALIBRATORS OFFERED BY MAJOR PLAYERS
TABLE 51
NUCLEAR MEDICINE EQUIPMENT MARKET FOR DOSE CALIBRATORS, BY REGION, 2023–2030 (USD MILLION)
TABLE 52
PROBE COUNTING SYSTEMS OFFERED BY MAJOR PLAYERS
TABLE 53
NUCLEAR MEDICINE EQUIPMENT MARKET FOR PROBE COUNTING SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 54
GAMMA WELL COUNTERS OFFERED BY MAJOR PLAYERS
TABLE 55
NUCLEAR MEDICINE EQUIPMENT MARKET FOR GAMMA WELL COUNTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 56
NUCLEAR MEDICINE EQUIPMENT MARKET FOR OTHER NON-IMAGING MODALITIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 57
NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 58
NUCLEAR MEDICINE EQUIPMENT FOR ONCOLOGY OFFERED BY MAJOR PLAYERS
TABLE 59
NUCLEAR MEDICINE EQUIPMENT MARKET FOR ONCOLOGY, BY REGION, 2023–2030 (USD MILLION)
TABLE 60
NUCLEAR MEDICINE EQUIPMENT FOR NEUROLOGY OFFERED BY MAJOR PLAYERS
TABLE 61
NUCLEAR MEDICINE EQUIPMENT MARKET FOR NEUROLOGY, BY REGION, 2023–2030 (USD MILLION)
TABLE 62
NUCLEAR MEDICINE EQUIPMENT FOR CARDIOLOGY OFFERED BY MAJOR PLAYERS
TABLE 63
NUCLEAR MEDICINE EQUIPMENT MARKET FOR CARDIOLOGY, BY REGION, 2023–2030 (USD MILLION)
TABLE 64
NUCLEAR MEDICINE EQUIPMENT FOR ORTHOPEDICS OFFERED BY MAJOR PLAYERS
TABLE 65
NUCLEAR MEDICINE EQUIPMENT MARKET FOR ORTHOPEDICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 66
NUCLEAR MEDICINE EQUIPMENT FOR THYROID OFFERED BY MAJOR PLAYERS
TABLE 67
NUCLEAR MEDICINE EQUIPMENT MARKET FOR THYROID, BY REGION, 2023–2030 (USD MILLION)
TABLE 68
NUCLEAR MEDICINE EQUIPMENT MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2023–2030 (USD MILLION)
TABLE 69
NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 70
NUCLEAR MEDICINE 2D EQUIPMENT OFFERED BY MAJOR PLAYERS
TABLE 71
NUCLEAR MEDICINE 2D EQUIPMENT MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 72
NUCLEAR MEDICINE 3D EQUIPMENT OFFERED BY MAJOR PLAYERS
TABLE 73
NUCLEAR MEDICINE 3D EQUIPMENT MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 74
NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 75
NUCLEAR MEDICINE EQUIPMENT FOR HOSPITALS OFFERED BY MAJOR PLAYERS
TABLE 76
NUCLEAR MEDICINE EQUIPMENT MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION)
TABLE 77
NUCLEAR MEDICINE EQUIPMENT FOR DIAGNOSTIC IMAGING CENTERS OFFERED BY MAJOR PLAYERS
TABLE 78
NUCLEAR MEDICINE EQUIPMENT MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 79
NUCLEAR MEDICINE EQUIPMENT FOR CANCER TREATMENT CENTERS OFFERED BY MAJOR PLAYERS
TABLE 80
NUCLEAR MEDICINE EQUIPMENT MARKET FOR CANCER TREATMENT CENTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 81
NUCLEAR MEDICINE EQUIPMENT FOR OTHER END USERS OFFERED BY MAJOR PLAYERS
TABLE 82
NUCLEAR MEDICINE EQUIPMENT MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 83
NUCLEAR MEDICINE EQUIPMENT MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 84
NORTH AMERICA: KEY MACROECONOMIC INDICATORS
TABLE 85
NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 86
NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 87
NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 88
NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 89
NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 90
NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 91
NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 92
NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 93
NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 94
US: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 95
US: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 96
US: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 97
US: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 98
US: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 99
US: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 100
US: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 101
US: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 102
CANADA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 103
CANADA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 104
CANADA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 105
CANADA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 106
CANADA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 107
CANADA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 108
CANADA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 109
CANADA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 110
EUROPE: KEY MACROECONOMIC INDICATORS
TABLE 111
EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 112
EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 113
EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 114
EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 115
EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE,2023–2030 (USD MILLION)
TABLE 116
EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE 2023–2030 (USD MILLION)
TABLE 117
EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 118
EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 119
EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 120
GERMANY: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 121
GERMANY: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 122
GERMANY: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 123
GERMANY: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 124
GERMANY: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 125
GERMANY: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 126
GERMANY: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 127
GERMANY: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 128
UK: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 129
UK: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 130
UK: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 131
UK: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 132
UK: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 133
UK: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 134
UK: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 135
UK: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 136
FRANCE: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 137
FRANCE: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 138
FRANCE: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 139
FRANCE: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 140
FRANCE: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 141
FRANCE: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 142
FRANCE: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 143
FRANCE: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 144
ITALY: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 145
ITALY: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 146
ITALY: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 147
ITALY: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 148
ITALY: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 149
ITALY: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 150
ITALY: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 151
ITALY: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 152
SPAIN: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 153
SPAIN: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES,BY TYPE, 2023–2030 (USD MILLION)
TABLE 154
SPAIN: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 155
SPAIN: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 156
SPAIN: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 157
SPAIN: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 158
SPAIN: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 159
SPAIN: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 160
SWEDEN: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 161
SWEDEN: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 162
SWEDEN: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 163
SWEDEN: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 164
SWEDEN: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 165
SWEDEN: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 166
SWEDEN: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 167
SWEDEN: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 168
REST OF EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 169
REST OF EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 170
REST OF EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 171
REST OF EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 172
REST OF EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 173
REST OF EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 174
REST OF EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 175
REST OF EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 176
ASIA PACIFIC: KEY MACROECONOMIC INDICATORS
TABLE 177
ASIA PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 178
ASIA PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 179
ASIA PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 180
ASIA PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 181
ASIA PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182
ASIA PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 183
ASIA PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 184
ASIA PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 185
ASIA PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 186
JAPAN: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 187
JAPAN: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 188
JAPAN: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 189
JAPAN: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 190
JAPAN: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 191
JAPAN: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 192
JAPAN: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION,2023–2030 (USD MILLION)
TABLE 193
JAPAN: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 194
CHINA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 195
CHINA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 196
CHINA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 197
CHINA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 198
CHINA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 199
CHINA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 200
CHINA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION,2023–2030 (USD MILLION)
TABLE 201
CHINA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 202
INDIA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 203
INDIA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 204
INDIA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 205
INDIA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 206
INDIA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 207
INDIA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA,2023–2030 (USD MILLION)
TABLE 208
INDIA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 209
INDIA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 210
SOUTH KOREA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 211
SOUTH KOREA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE 2023–2030 (USD MILLION)
TABLE 212
SOUTH KOREA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 213
SOUTH KOREA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 214
SOUTH KOREA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 215
SOUTH KOREA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 216
SOUTH KOREA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 217
SOUTH KOREA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 218
AUSTRALIA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 219
AUSTRALIA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 220
AUSTRALIA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 221
AUSTRALIA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 222
AUSTRALIA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 223
AUSTRALIA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 224
AUSTRALIA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION,2023–2030 (USD MILLION)
TABLE 225
AUSTRALIA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 226
REST OF ASIA PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 227
REST OF ASIA PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 228
REST OF ASIA PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 229
REST OF ASIA PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 230
REST OF ASIA PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 231
REST OF ASIA PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 232
REST OF ASIA PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 233
REST OF ASIA PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 234
MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS
TABLE 235
MIDDLE EAST & AFRICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 236
MIDDLE EAST & AFRICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 237
MIDDLE EAST & AFRICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 238
MIDDLE EAST & AFRICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 239
MIDDLE EAST & AFRICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 240
MIDDLE EAST & AFRICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 241
MIDDLE EAST & AFRICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 242
MIDDLE EAST & AFRICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 243
MIDDLE EAST & AFRICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 244
GCC COUNTRIES: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 245
GCC COUNTRIES: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 246
GCC COUNTRIES: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 247
GCC COUNTRIES: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 248
GCC COUNTRIES: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 249
GCC COUNTRIES: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 250
GCC COUNTRIES: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 251
GCC COUNTRIES: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 252
REST OF MIDDLE EAST & AFRICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 253
REST OF MIDDLE EAST & AFRICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 254
REST OF MIDDLE EAST & AFRICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 255
REST OF MIDDLE EAST & AFRICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 256
REST OF MIDDLE EAST & AFRICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 257
REST OF MIDDLE EAST & AFRICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 258
REST OF MIDDLE EAST & AFRICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 259
REST OF MIDDLE EAST & AFRICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 260
LATIN AMERICA: KEY MACROECONOMIC INDICATORS
TABLE 261
LATIN AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 262
LATIN AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 263
LATIN AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 264
LATIN AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 265
LATIN AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 266
LATIN AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 267
LATIN AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 268
LATIN AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 269
LATIN AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 270
BRAZIL: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 271
BRAZIL: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 272
BRAZIL: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 273
BRAZIL: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 274
BRAZIL: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 275
BRAZIL: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 276
BRAZIL: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 277
BRAZIL: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 278
MEXICO: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 279
MEXICO: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 280
MEXICO: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 281
MEXICO: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 282
MEXICO: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE 2023–2030 (USD MILLION)
TABLE 283
MEXICO: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 284
MEXICO: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 285
MEXICO: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 286
REST OF LATIN AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION)
TABLE 287
REST OF LATIN AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 288
REST OF LATIN AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 289
REST OF LATIN AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 290
REST OF LATIN AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET FOR NON-IMAGING MODALITIES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 291
REST OF LATIN AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
TABLE 292
REST OF LATIN AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2023–2030 (USD MILLION)
TABLE 293
REST OF LATIN AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 294
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NUCLEAR MEDICINE EQUIPMENT MARKET, JANUARY 2022–JUNE 2025
TABLE 295
NUCLEAR MEDICINE EQUIPMENT MARKET: DEGREE OF COMPETITION
TABLE 296
POSITRON EMISSION TOMOGRAPHY (PET) EQUIPMENT MARKET: DEGREE OF COMPETITION
TABLE 297
SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) EQUIPMENT MARKET: DEGREE OF COMPETITION
TABLE 298
NUCLEAR MEDICINE EQUIPMENT MARKET: REGION FOOTPRINT
TABLE 299
NUCLEAR MEDICINE EQUIPMENT MARKET: SYSTEM TYPE FOOTPRINT
TABLE 300
NUCLEAR MEDICINE EQUIPMENT MARKET: THERAPEUTIC AREA FOOTPRINT
TABLE 301
NUCLEAR MEDICINE EQUIPMENT MARKET: DIMENSION FOOTPRINT
TABLE 302
NUCLEAR MEDICINE EQUIPMENT MARKET: END-USER FOOTPRINT
TABLE 303
NUCLEAR MEDICINE EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 304
NUCLEAR MEDICINE EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF SMES/STARTUPS
TABLE 305
NUCLEAR MEDICINE EQUIPMENT MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025
TABLE 306
NUCLEAR MEDICINE EQUIPMENT MARKET: DEALS, JANUARY 2022–JUNE 2025
TABLE 307
NUCLEAR MEDICINE EQUIPMENT MARKET: EXPANSIONS, JANUARY 2022–JUNE 2025
TABLE 308
NUCLEAR MEDICINE EQUIPMENT MARKET: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025
TABLE 309
GE HEALTHCARE: COMPANY OVERVIEW
TABLE 310
GE HEALTHCARE: PRODUCTS OFFERED
TABLE 311
GE HEALTHCARE: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025
TABLE 312
GE HEALTHCARE: DEALS, JANUARY 2022–JUNE 2025
TABLE 313
GE HEALTHCARE: EXPANSIONS, JANUARY 2022–JUNE 2025
TABLE 314
SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
TABLE 315
SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
TABLE 316
SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025
TABLE 317
SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–JUNE 2025
TABLE 318
KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 319
KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
TABLE 320
KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025
TABLE 321
KONINKLIJKE PHILIPS N.V: DEALS, JANUARY 2022–JUNE 2025
TABLE 322
MIRION TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 323
MIRION TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 324
MIRION TECHNOLOGIES, INC.: PRODUCT LAUNCHES AND APPROVALS,JANUARY 2022–JUNE 2025
TABLE 325
MIRION TECHNOLOGIES, INC.: DEALS, JANUARY 2022–JUNE 2025
TABLE 326
CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
TABLE 327
CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED
TABLE 328
CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2022–JUNE 2025
TABLE 329
HERMES MEDICAL SOLUTIONS: COMPANY OVERVIEW
TABLE 330
HERMES MEDICAL SOLUTIONS: PRODUCTS OFFERED
TABLE 331
HERMES MEDICAL SOLUTIONS: PRODUCT LAUNCHES AND APPROVALS,JANUARY 2022–JUNE 2025
TABLE 332
HERMES MEDICAL SOLUTIONS: DEALS, JANUARY 2022–JUNE 2025
TABLE 333
HERMES MEDICAL SOLUTIONS: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025
TABLE 334
DOSISOFT SA: COMPANY OVERVIEW
TABLE 335
DOSISOFT SA: PRODUCTS OFFERED
TABLE 336
DOSISOFT SA: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025
TABLE 337
DOSISOFT SA: DEALS, JANUARY 2022–JUNE 2025
TABLE 338
SEGAMI CORPORATION: COMPANY OVERVIEW
TABLE 339
SEGAMI CORPORATION: PRODUCTS OFFERED
TABLE 340
WINKGEN MEDICAL SYSTEMS GMBH & CO. KG: COMPANY OVERVIEW
TABLE 341
WINKGEN MEDICAL SYSTEMS GMBH & CO. KG: PRODUCTS OFFERED
TABLE 342
WINKGEN MEDICAL SYSTEMS GMBH & CO. KG: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025
TABLE 343
WINKGEN MEDICAL SYSTEMS GMBH & CO. KG: DEALS,JANUARY 2022–JUNE 2025
TABLE 344
COMECER S.P.A.: COMPANY OVERVIEW
TABLE 345
COMECER S.P.A.: PRODUCTS OFFERED
TABLE 346
COMECER S.P.A.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025
TABLE 347
COMECER S.P.A.: DEALS, JANUARY 2022–JUNE 2025
TABLE 348
COMECER S.P.A.: EXPANSIONS, JANUARY 2022–JUNE 2025
TABLE 349
SYNTERMED INC.: COMPANY OVERVIEW
TABLE 350
SYNTERMED INC.: PRODUCTS OFFERED
TABLE 351
SYNTERMED INC.: DEALS, JANUARY 2022–JUNE 2025
TABLE 352
ULTRASPECT INC.: PRODUCTS OFFERED
TABLE 353
LABLOGIC SYSTEMS LTD.: COMPANY OVERVIEW
TABLE 354
LABLOGIC SYSTEMS LTD.: PRODUCTS OFFERED
TABLE 355
LABLOGIC SYSTEMS LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025
TABLE 356
LABLOGIC SYSTEMS LTD.: DEALS, JANUARY 2022–JUNE 2025
TABLE 357
LABLOGIC SYSTEMS LTD.: EXPANSIONS, JANUARY 2022–JUNE 2025
TABLE 358
MEDISO LTD.: COMPANY OVERVIEW
TABLE 359
MEDISO LTD.: PRODUCTS OFFERED
TABLE 360
MEDISO LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025
TABLE 361
CATALYST MEDTECH: COMPANY OVERVIEW
TABLE 362
CATALYST MEDTECH: PRODUCTS OFFERED
TABLE 363
CATALYST MEDTECH: DEALS, JANUARY 2022–JUNE 2025
TABLE 364
CATALYST MEDTECH: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025
TABLE 365
LEMER PAX: COMPANY OVERVIEW
TABLE 366
LEMER PAX: PRODUCTS OFFERED
TABLE 367
LEMER PAX: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025
TABLE 368
LEMER PAX: DEALS, JANUARY 2022–JUNE 2025
TABLE 369
SPECTRUM DYNAMICS MEDICAL: COMPANY OVERVIEW
TABLE 370
SPECTRUM DYNAMICS MEDICAL: PRODUCTS OFFERED
TABLE 371
SPECTRUM DYNAMICS MEDICAL: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025
TABLE 372
SPECTRUM DYNAMICS MEDICAL: DEALS, JANUARY 2022–JUNE 2025
TABLE 373
NEUSOFT MEDICAL SYSTEMS CO.,?LTD.: COMPANY OVERVIEW
TABLE 374
NEUSOFT MEDICAL SYSTEMS CO., LTD.: PRODUCTS OFFERED
TABLE 375
NEUSOFT MEDICAL SYSTEMS CO., LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025
TABLE 376
NEUSOFT MEDICAL SYSTEMS CO., LTD.: DEALS, JANUARY 2022–JUNE 2025
TABLE 377
BRAINLAB SE: COMPANY OVERVIEW
TABLE 378
BRAINLAB SE: PRODUCTS OFFERED
TABLE 379
BRAINLAB SE: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025
TABLE 380
BRAINLAB SE: DEALS, JANUARY 2022–JUNE 2025
TABLE 381
MIRADA MEDICAL: COMPANY OVERVIEW
TABLE 382
MIRADA MEDICAL: PRODUCTS OFFERED
TABLE 383
MIRADA MEDICAL: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025
TABLE 384
MIRADA MEDICAL: DEALS, JANUARY 2022–JUNE 2025
TABLE 385
TRASIS: COMPANY OVERVIEW
TABLE 386
SOFIE: COMPANY OVERVIEW
TABLE 387
ITM ISOTOPE TECHNOLOGIES MUNICH SE: COMPANY OVERVIEW
TABLE 388
POSITRIGO AG: COMPANY OVERVIEW
TABLE 389
PAIRE: COMPANY OVERVIEW
FIGURE 1
NUCLEAR MEDICINE EQUIPMENT MARKET SEGMENTATION AND REGIONAL SCOPE
FIGURE 3
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 5
BOTTOM-UP APPROACH
FIGURE 6
TOP-DOWN APPROACH
FIGURE 7
CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS
FIGURE 8
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 9
DATA TRIANGULATION METHODOLOGY
FIGURE 10
NUCLEAR MEDICINE EQUIPMENT MARKET, BY SYSTEM TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 11
NUCLEAR MEDICINE EQUIPMENT MARKET, BY DIMENSION, 2025 VS. 2030 (USD MILLION)
FIGURE 12
NUCLEAR MEDICINE EQUIPMENT MARKET, BY THERAPEUTIC AREA, 2025 VS. 2030 (USD MILLION)
FIGURE 13
NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 14
NUCLEAR MEDICINE EQUIPMENT MARKET: REGIONAL SNAPSHOT
FIGURE 15
GROWING ADOPTION OF ADVANCED IMAGING MODALITIES AND EXPANSION OF THERANOSTICS TO DRIVE MARKET
FIGURE 16
ONCOLOGY SEGMENT AND JAPAN LED ASIA PACIFIC MARKET IN 2024
FIGURE 17
INDIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 18
ASIA PACIFIC TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 19
EMERGING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
FIGURE 20
NUCLEAR MEDICINE EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 21
REVENUE SHIFT AND NEW REVENUE POCKETS IN NUCLEAR MEDICINE EQUIPMENT MARKET
FIGURE 22
AVERAGE SELLING PRICE OF NUCLEAR CARDIOLOGY REPORTING SOFTWARE, 2024 (USD)
FIGURE 23
NUCLEAR MEDICINE EQUIPMENT MARKET: VALUE CHAIN ANALYSIS
FIGURE 24
NUCLEAR MEDICINE EQUIPMENT MARKET: ECOSYSTEM ANALYSIS
FIGURE 25
INVESTMENT AND FUNDING SCENARIO, 2015–2025
FIGURE 26
NUCLEAR MEDICINE EQUIPMENT MARKET: PATENT ANALYSIS, 2015–2025
FIGURE 27
NUCLEAR MEDICINE EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 28
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
FIGURE 29
KEY BUYING CRITERIA FOR END USERS
FIGURE 30
MARKET POTENTIAL OF AI/GEN AI ON NUCLEAR MEDICINE EQUIPMENT ACROSS INDUSTRIES
FIGURE 31
IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
FIGURE 32
NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET SNAPSHOT, 2024
FIGURE 33
ASIA PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET SNAPSHOT, 2024
FIGURE 34
REVENUE ANALYSIS OF KEY PLAYERS IN NUCLEAR MEDICINE EQUIPMENT MARKET, 2020–2024
FIGURE 35
NUCLEAR MEDICINE EQUIPMENT MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
FIGURE 36
POSITRON EMISSION TOMOGRAPHY (PET) EQUIPMENT MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
FIGURE 37
SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) EQUIPMENT MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
FIGURE 38
MARKET RANKING ANALYSIS OF KEY PLAYERS, 2024
FIGURE 39
NUCLEAR MEDICINE EQUIPMENT MARKET: BRAND/PRODUCT COMPARISON
FIGURE 40
EV/EBITDA OF KEY VENDORS
FIGURE 41
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
FIGURE 42
NUCLEAR MEDICINE EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 43
NUCLEAR MEDICINE EQUIPMENT MARKET: COMPANY FOOTPRINT
FIGURE 44
NUCLEAR MEDICINE EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 45
GE HEALTHCARE: COMPANY SNAPSHOT (2024)
FIGURE 46
SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024)
FIGURE 47
KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024)
FIGURE 48
MIRION TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 49
CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 50
NEUSOFT MEDICAL SYSTEMS CO.,?LTD.: COMPANY SNAPSHOT (2024)
Growth opportunities and latent adjacency in Nuclear Medicine Equipment Market